Florida Cancer Specialists & Research Institute | Association Partnerships

Florida’s Largest Community Oncology Practice Contributes Study Results in 23 Abstracts, Presentations and Publications.

Results of year-long collaborative effort between Florida Cancer Specialists & Research Institute and CVS Health/Aetna documented in newly released case study.

Lucio N. Gordan, MD, will join an expert panel of precision medicine leaders in Chicago this weekend to discuss the impact of genomic profiling.

Florida Cancer Specialists & Research Institute, LLC has named Wilfredo Blasini, MD as Medical Director of the Central Pathology Laboratory.

Florida Cancer Specialists & Research Institute Demands Change, Encourages Legislative Action

Ana Van Der Wall, MD, reflects on her mother’s influence to become a medical oncologist.

A known leader in value-based oncology care, Florida Cancer Specialists & Research Institute, LLC continues to forge new partnerships with alternative payment models and payers.

Florida Cancer Specialists & Research Institute President & Managing Physician Lucio Gordan, MD, Featured Speaker at Nationwide Oncology Event – Joins Pulitzer Prize Winning Author to Discuss How Genetics are Advancing Cancer Care.

Florida Cancer Specialists & Research Institute, LLC celebrated the opening of its new clinic location in Clermont with a ribbon-cutting ceremony on Thursday, April 27, 2023.

Florida Cancer Specialists & Research Institute, LLC welcomes 2 Board-certified medical oncologists to its Delray clinic in Palm Beach County.

Case Study Details Evolution of New First-Line Therapy

Florida Cancer Specialists & Research Institute Medical Oncologist Barry Berman, MD, MS, Serves on ASCO Anxiety & Depression Update Expert Panel.

Florida Cancer Specialists & Research Institute Leads Discussions on Cancer Care Challenges at 2023 FLASCO Business of Oncology Summit & Spring Session.

A new study using data from Florida Cancer Specialists & Research Institute, LLC evaluates the effects of chemotherapy-induced myelosuppression for extensive-stage small cell lung cancer.

The effects of chemotherapy-induced myelosuppression for extensive-stage small cell lung cancer were assessed in a new study which used a real-world community oncology setting.

Members from Florida Cancer Specialists & Research Institute envision the next 20 years in community oncology care.

Experts from Florida Cancer Specialists & Research Institute will join with colleagues to share the latest advances in oncology pharmacy operations and dispensing practices at the NCODA 2023 Spring Forum in Indianapolis.

Miguel Pelayo, MD, discusses what he sees as practice-changing treatments for patients with triple-negative breast cancer and how he helps patients feel confident in these new treatments.

The FDA has approved the first non-covalent Bruton tyrosine kinase inhibitor for the treatment of relapsed or refractory mantle cell lymphoma in adult patients, based on clinical studies conducted with participation by Florida Cancer Specialists & Research Institute.

Next generation sequencing is at the forefront of where technology and oncology intersect to help optimize patient outcomes and expand the overall field of cancer care.

FCS has announcde that Hitesh Patel, MD has joined its Executive Board, effective January 27, 2023.

Popular Peloton® cycling instructor Leanne Hainsby revealed last weekend in an Instagram post that she is undergoing treatment for breast cancer.

Florida Cancer Specialists & Research Institute, LLC, announces that James A. Reeves Jr, MD will retire from its Research Division, effective January 31, 2023.

Florida Cancer Specialists & Research Institute, LLC welcomes Board-certified hematologist and medical oncologist Pavankumar Tandra, MD to the Sarasota Downtown clinic.

American Oncology Network, LLC announced the addition of medical oncologists to the Board of Managers, effective January 1.

Lucio Gordan, MD, has assumed the role of President & Managing Physician at Florida Cancer Specialists & Research Institute.

During a Targeted Oncology case-based roundtable event, Rami Komrokji, MD, discussed with participants their approach toward assessing and treating a patient with symptoms possibly indicating primary myelofibrosis.

In an interview with Targeted Oncology, Gustavo Fonseca, MD, FACP, discussed the positive health-related quality of life findings in patients with diffuse large B-cell lymphoma from the POLARIX study.

Three members of the Senior Management Team have been promoted at the Florida Cancer Specialists & Research Institute.

Florida Cancer Specialists & Research Institute, LLC is pleased to announce that Board-certified hematologist and medical oncologist William T. McGarry, MD has joined the statewide practice.